KalVista Pharmaceuticals, Inc. ( KALV) - Key Metrics
KALV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q3 | $1.19 | -$0.11 | ? | ? |
| 2026Q2 | ? | ? | ? | ? |
| 2026Q2 | $0.25 | -$0.92 | -$0.61 | -$0.61 |
| 2026Q1 | $0.03 | -$1.12 | -$1.02 | -$1.02 |
KALV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q3 | ? | -37.98 |
| 2026Q2 | ? | ? |
| 2026Q2 | ? | -3.32 |
| 2026Q1 | ? | -3.03 |
KALV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 4.47% | ? |
| 2026Q3 | -1.77% | ? |
| 2026Q2 | ? | ? |
| 2026Q2 | -4.98% | ? |
| 2026Q1 | -7.51% | ? |
KALV
Price: $27
52 week price:
Earnings Per Share: -3.94 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 731100
Ebitda: -22.6 millionMarket Capitalization: 1.4 billion